Sechi G, Sechi M
Int J Mol Sci. 2024; 25(20).
PMID: 39456980
PMC: 11508228.
DOI: 10.3390/ijms252011198.
Lee H, Choe J, Son M, Lee I, Lim M, Jeon J
Antioxidants (Basel). 2024; 13(8).
PMID: 39199189
PMC: 11352053.
DOI: 10.3390/antiox13080943.
Fornstedt Wallin B
J Neural Transm (Vienna). 2024; 131(3):213-228.
PMID: 38238531
DOI: 10.1007/s00702-023-02718-2.
Shukla D, Goel A, Mandal P, Joon S, Punjabi K, Arora Y
ACS Chem Neurosci. 2023; 14(24):4383-4394.
PMID: 38050970
PMC: 10739611.
DOI: 10.1021/acschemneuro.3c00717.
Dogaru C, Duta C, Muscurel C, Stoian I
Int J Mol Sci. 2023; 24(20).
PMID: 37895024
PMC: 10607139.
DOI: 10.3390/ijms242015344.
The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons.
Franco R, Serrano-Marin J, Navarro G, Rivas-Santisteban R
Antioxidants (Basel). 2023; 12(10).
PMID: 37891948
PMC: 10604245.
DOI: 10.3390/antiox12101869.
Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond.
Martinez-Banaclocha M
Antioxidants (Basel). 2023; 12(7).
PMID: 37507913
PMC: 10376658.
DOI: 10.3390/antiox12071373.
Reactive oxygen species formation and its effect on CD4 T cell-mediated inflammation.
Shu P, Liang H, Zhang J, Lin Y, Chen W, Zhang D
Front Immunol. 2023; 14:1199233.
PMID: 37304262
PMC: 10249013.
DOI: 10.3389/fimmu.2023.1199233.
Mitochondrial Complex I Inhibition in Dopaminergic Neurons Causes Altered Protein Profile and Protein Oxidation: Implications for Parkinson's disease.
Chithra Y, Dey G, Ghose V, Chandramohan V, Gowthami N, Vasudev V
Neurochem Res. 2023; 48(8):2360-2389.
PMID: 36964824
DOI: 10.1007/s11064-023-03907-x.
Increased cysteine metabolism in PINK1 models of Parkinson's disease.
Travaglio M, Michopoulos F, Yu Y, Popovic R, Foster E, Coen M
Dis Model Mech. 2023; 16(1).
PMID: 36695500
PMC: 9903142.
DOI: 10.1242/dmm.049727.
Cellular and Molecular Events Leading to Paraquat-Induced Apoptosis: Mechanistic Insights into Parkinson's Disease Pathophysiology.
See W, Naidu R, Tang K
Mol Neurobiol. 2022; 59(6):3353-3369.
PMID: 35306641
PMC: 9148284.
DOI: 10.1007/s12035-022-02799-2.
-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases.
Martinez-Banaclocha M
Antioxidants (Basel). 2022; 11(2).
PMID: 35204298
PMC: 8869501.
DOI: 10.3390/antiox11020416.
Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase.
Segura-Aguilar J, Munoz P, Inzunza J, Varshney M, Nalvarte I, Mannervik B
Antioxidants (Basel). 2022; 11(2).
PMID: 35204179
PMC: 8868244.
DOI: 10.3390/antiox11020296.
Parkinson's Disease and the Metal-Microbiome-Gut-Brain Axis: A Systems Toxicology Approach.
Forero-Rodriguez L, Josephs-Spaulding J, Flor S, Pinzon A, Kaleta C
Antioxidants (Basel). 2022; 11(1).
PMID: 35052575
PMC: 8773335.
DOI: 10.3390/antiox11010071.
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease.
Wang Y, Gao L, Chen J, Li Q, Huo L, Wang Y
Front Pharmacol. 2021; 12:757161.
PMID: 34887759
PMC: 8650509.
DOI: 10.3389/fphar.2021.757161.
Regulation of Tissue Inflammation by 12-Lipoxygenases.
Kulkarni A, Nadler J, Mirmira R, Casimiro I
Biomolecules. 2021; 11(5).
PMID: 34064822
PMC: 8150372.
DOI: 10.3390/biom11050717.
Intersection between Redox Homeostasis and Autophagy: Valuable Insights into Neurodegeneration.
Park H, Kim J, Shin C, Lee S
Antioxidants (Basel). 2021; 10(5).
PMID: 33924878
PMC: 8146521.
DOI: 10.3390/antiox10050694.
The Effect of Oxidized Dopamine on the Structure and Molecular Chaperone Function of the Small Heat-Shock Proteins, αB-Crystallin and Hsp27.
Hayashi J, Ton J, Negi S, Stephens D, Pountney D, Preiss T
Int J Mol Sci. 2021; 22(7).
PMID: 33918165
PMC: 8037807.
DOI: 10.3390/ijms22073700.
Fibrillar α-synuclein toxicity depends on functional lysosomes.
Guiney S, Adlard P, Lei P, Mawal C, Bush A, Finkelstein D
J Biol Chem. 2021; 295(51):17497-17513.
PMID: 33453994
PMC: 7762966.
DOI: 10.1074/jbc.RA120.013428.
Phenotypic assays in yeast and zebrafish reveal drugs that rescue deficiency.
Heins-Marroquin U, Jung P, Cordero-Maldonado M, Crawford A, Linster C
Brain Commun. 2020; 1(1):fcz019.
PMID: 32954262
PMC: 7425419.
DOI: 10.1093/braincomms/fcz019.